Lisette Hilton

Rare aggressive cutaneous lymphoma puts patients at risk of thyroid and non-lymphocytic leukemia second primary malignancies, researchers say.

Toning and strength technologies work, according to investigators, but many in cosmetic medicine question the procedures' efficacy in their field.

Experts discuss the impact of misinformation in medicine at the current ACAAI annual scientific meeting.

Experts discuss the impact of misinformation in medicine at the current ACAAI annual scientific meeting.

Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.

Cantharidin 0.7% could be an emerging standard for molluscum treatment.

Optimizing rosacea treatment outcomes isn’t only about papules and pustules. Facial erythema needs to be part of an effective management plan.

COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.

Postpartum hair loss can cause acute emotional burden, according to Alan J. Bauman, MD, ABHRS, FISHRS, and physicians must be aware of the considerations needed for this patient group.

When used incorrectly or inaccurately, cryolipolysis can, in rare cases, result in SAEs including dysesthesia, pain, paradoxical adipose hyperplasia, skin blanching, vasovagal reactions, skin hyperpigmentation, contour irregularities, and nerve injuries.

As COVID-19 eases, the FDA is breaking through its backlog and clinical trials are moving forward, opening the way for a new wave of treatments.

Mark Mandell-Brown, MD, details his treatment protocol for addressing female to male breast reduction surgically and through minimally invasive procedures.

The pro-inflammatory transcription factor is critical for the expression of IL-23, which is known to play a role in psoriasis.

Experts present detailed guidelines on how to diagnose and treat common skin diseases and conditions in the Asian American population.

Women’s use of facial skin care products saw a significant rise in 2020 due to the COVID-19 pandemic, according to The NPD Group, a market research company.

Creating a skin care line involves dedication, product testing, clinical trials, marketing, sales, and yes, a lot of money.

Experts evaluate efficacy and safety of regenerative skin care products.

Experts evaluate the efficacy, safety of regenerative skin care products.

Study findings show calcipotriene-betamethasone foam to be safe and moderately effective in skin of color patients with psoriasis but failed to meet several secondary endpoints and to demonstrate statistically significant changes.

Joshua A. Lampert, MD, highlights power-assisted liposuction devices and new finer fat grafting harvest cannulas to help avoid exposure to ambient air.

Suneel Chilukuri, MD, discusses body contouring devices taking over the specialty in 2021.

As the COVID-19 pandemic slowly starts to ease, new questions arise about legalities related to vaccine requirements and medical practice staff.

Although the pandemic brought uncertainty for many physicians and medical practices, many report financial success in 2020.

The decision between surgical and nonsurgical options for chin augmentation continues to be a debate, but according to Michael Somenek, MD, this can be easily settled with personalized patient consultation.

As EON touchless technology enters the practice, questions about how to market the procedure, comparison with competing devices, and evaluation of retail pricing, arise.

Dominion’s EON device shows safety and efficacy in subcutaneous fat reduction, according to EON study investigator, Thomas Fiala, MD, FACS.

While radiofrequency technology continues to improve, surgical intervention still reigns supreme for eye, and neck rejuvenation.

Suneel Chilukuri, MD, and Mark M. Beaty, MD, discuss the evolution of radiofrequency technology, and which devices they reach for.

Recently approved treatments for acne are focused on decreasing activity within the sebaceous gland.

The investigational neuromodulator, evaluated in clinical trials as a treatment for glabellar lines and as a combined therapy for glabellar, dynamic forehead, and lateral canthal lines, is quickly nearing an approval by the FDA.